An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

NCT02294461 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Progressive Metastatic Prostate Cancer

Interventions

DRUG: Enzalutamide
DRUG: Placebo

Sponsor

Astellas Pharma Inc